Titan Pharmaceuticals Inc. (NASDAQ:TTNP) shares moved down -1.89% in last trading session and ended the day at $5.19. TTNP has a return on assets of -53.10%.
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and partner Braeburn Pharmaceuticals announced that the U.S. Food and Drug Administration has scheduled a meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) on Jan. 12, 2016 to review the New Drug Application (NDA) for Probuphine® for the maintenance treatment of opioid addiction.
TransGlobe Energy Corporation (NASDAQ:TGA) ended the last trading day at $1.73. Company weekly volatility is calculated as 7.35% and price to cash ratio as 1.03. TransGlobe Energy Corporation (NASDAQ:TGA) showed a weekly performance of -17.22%.
TransGlobe Energy Corporation (NASDAQ:TGA) announces that its Board of Directors has approved a capital budget of $41 million for 2016 and declared a quarterly dividend of US$0.025 per common share, which will be paid in cash on December 31, 2015 to shareholders of record on December 15, 2015.
On 09 December, Century Bancorp Inc. (NASDAQ:CNBKA) shares remains unchanged and was closed at $43.90. CNBKA EPS growth in last 5 year was 9.50%. Century Bancorp Inc. (NASDAQ:CNBKA) year to date (YTD) performance is 9.59%.
Kinder Morgan, Inc. (NYSE:KMI) shares moved up 6.93% in last trading session and ended the day at $16.81. KMI Gross Margin is 52.80% and its has a return on assets of 1.30%. Kinder Morgan, Inc. (NYSE:KMI) quarterly performance is -43.85%.
Kinder Morgan Inc. (NYSE:KMI) announced that its board has approved a plan pursuant to which it expects to pay quarterly dividends of $0.125 per share to its common stockholders ($0.50 annually), down from its current quarterly level of $0.51, beginning with the fourth quarter 2015 dividend payable in February 2016.
Genocea Biosciences, Inc. (NASDAQ:GNCA) caters to the Healthcare space. Its weekly performance is -7.87%. On the last day of trading company shares ended up at $5.97. Genocea Biosciences, Inc. (NASDAQ:GNCA) distance from 50-day simple moving average (SMA50) is -0.08%.
Genocea Biosciences, Inc. (NASDAQ:GNCA), announced that Chip Clark, president and chief executive officer, presented a company overview at Piper Jaffray 27th Annual Healthcare Conference on Tuesday, December 1, 2015 at 12:30 p.m. ET in New York, NY.
Leave a Reply